Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Details on Person Orlic-Milacic, Marija, 2019-10-30

Class:Id	InstanceEdit:9665241
_displayName	Orlic-Milacic, Marija, 2019-10-30
_timestamp	2019-10-30 14:10:07
author	[Person:1169272] Orlic-Milacic, Marija
dateTime	2019-10-30 14:10:07
(authored)	[FailedReaction:9665232] Resistant ERBB2 KD mutants do not bind trastuzumab [Homo sapiens] [Pathway:9665233] Resistance of ERBB2 KD mutants to trastuzumab [Homo sapiens] [Pathway:9665244] Resistance of ERBB2 KD mutants to sapitinib [Homo sapiens] [Pathway:9665245] Resistance of ERBB2 KD mutants to tesevatinib [Homo sapiens] [Pathway:9665246] Resistance of ERBB2 KD mutants to neratinib [Homo sapiens] [Pathway:9665247] Resistance of ERBB2 KD mutants to osimertinib [Homo sapiens] [Pathway:9665249] Resistance of ERBB2 KD mutants to afatinib [Homo sapiens] [Pathway:9665250] Resistance of ERBB2 KD mutants to AEE788 [Homo sapiens] [Pathway:9665251] Resistance of ERBB2 KD mutants to lapatinib [Homo sapiens] [FailedReaction:9665278] Resistant ERBB2 KD mutants do not bind AEE788 [Homo sapiens] List all 23 refering instances
(modified)	[Pathway:1227990] Signaling by ERBB2 in Cancer [Homo sapiens]
[Change default viewing format]

No pathways have been reviewed or authored by Orlic-Milacic, Marija, 2019-10-30 (9665241)